WHO ICTRP trial
Effects of beta-hydroxy-beta-methylbutyrate supplementation in decompensated…
TCTR20240422012 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20240422012 |
|---|---|
| Public title | Effects of beta-hydroxy-beta-methylbutyrate supplementation in decompensated cirrhosis patients with sarcopenia: Randomize controlled trial, Preliminary Study |
| Scientific title | The Effects of beta-hydroxy-beta-methylbutyrate supplementation in decompensated cirrhosis patients with sarcopenia: Randomize controlled trial, Preliminary Study |
| Primary sponsor | Khon Kaen University |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 0 |
| Countries | Thailand |
| Conditions | Decompensated cirrhosis is associated with poor outcomes, especially when combined with sarcopenia. Cirrhosis, Sarcopenia, Beta-hydroxy beta-methylbutyrate;Cirrhosis, Sarcopenia, Beta-hydroxy beta-methylbutyrate |
| Interventions | Each serving provides 262 kcal, 10.5 g protein, 8.48 g fat, 34.2 g carbohydrate, 7.75 mcg (310 IU) Vitamin D3, and 0.74 g calcium HMB. 6 scoops mixed with 185 ml of water, twice a day morning and once before bedtime 12-week period… |
| Registration date | Apr 22, 2024 |
| Target size | 60 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: